Clarus Corp

Except as set forth below, there have been no material changes in our risk factors from those disclosed in Part I, Item 1A. of the Company’s Annual Report on Form 10-K for the year ended December 31, 2025.

Our review of strategic alternatives may not result in any transaction or other strategic outcome and could adversely affect our business, results of operations and stock price.

We have announced that our Board of Directors has initiated a review of strategic alternatives to enhance shareholder value. There can be no assurance that this review will result in any transaction or other strategic outcome, or as to the timing, terms, structure or completion of any such transaction or outcome. The review process may involve significant costs, divert management’s attention, disrupt our business and operations, and create uncertainty for our employees, customers, suppliers and other business partners. In addition, any potential transaction or other strategic outcome may be subject to risks and uncertainties, including market conditions, financing availability, regulatory approvals, third-party consents and the negotiation and execution of definitive agreements. We may determine to suspend or terminate the review process at any time, and we do not intend to provide updates regarding the review unless and until our Board of Directors approves a specific transaction or other strategic outcome, or otherwise determines that disclosure is appropriate or required. If the review does not result in a transaction or other strategic outcome, or if any transaction or outcome is delayed, not completed or viewed unfavorably, our business, financial condition, results of operations and stock price could be adversely affected.